Vadimezan (AS-A404)
Revision as of 02:07, 26 July 2023 by Warner-admin (talk | contribs) (Warner-admin moved page Vadimezan (ASA404) to Vadimezan (ASA-404) without leaving a redirect)
Mechanism of action
From the NCI Drug Dictionary: A fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.